Financials

News Ideas Discussions Technicals Forecast Seasonals

0QN1 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) operating, investing, and financing activities

0QN1 free cash flow for H2 24 is -20.32 M CHF. For 2024, 0QN1 free cash flow was -35.68 M CHF and operating cash flow was -35.53 M CHF.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CHF

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—